FindTrial
Sign In

Topical mupirocin or gentamicin cream at the exit site for prevention of peritoneal dialysis catheter-related infections and withdrawal from peritoneal dialysis.

Topical mupirocin or gentamicin cream at the exit site for prevention of peritoneal dialysis catheter-related infections and withdrawal from peritoneal dialysis. - Topical antibiotics cream at the exit site of peritoneal dialysis patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000034437
Enrollment
100
Registered
2018-10-15
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease

Interventions

None listed

Sponsors

The Japanese Society of dialysis and therapy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Peritoneal dialysis patients

Exclusion criteria

Exclusion criteria: Recent use of antibiotics Under 18 years of age active infection

Design outcomes

Primary

MeasureTime frame
Peritonitis—

Secondary

MeasureTime frame
Exit site infection Technical failure Adverse event—

Countries

Japan

Contacts

Public ContactNaohiro Toda

Kansai Electric Power Hospital Division of Nephrology

natoda@kuhp.kyoto-u.ac.jp+81-6-6458-5821

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026